LBNL Logo ONHS Funding Opportunity Report

DOW Combat Readiness – Medical Research Program Translational Research Award

Solicitation ID: HT942526CRRPTRA

Agency: DHA

Type: Cooperative Agreement
Deadline: 2026-11-18T00:00:00 ET
Eligibility: Yes (Unrestricted)
Funding: Up to $2.45M total per award, consisting of a $1.45M base award and a $1.00M optional research effort. The program expects to fund approximately three awards from a total budget of $4.37M.
Doc Type: BAA
Clearance: No
Program Manager: help@eBRAP.org
Last Updated: 2026-08-19 14:42
Analyzed File: HT942526CRRPTRA_GG.pdf

Eligibility Reasoning

Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. Applications from investigators within the DOW and applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged. Intragovernmental obligations of funding will be made according to the terms of a negotiated Inter-Agency Agreement and managed by a CDMRP Science Officer.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven, high-impact translational research to accelerate the development of solutions for trauma care to maximize casualty survivability and improve patient care closer to the point of injury. Research must address at least one of three focus areas: Battlefield diagnostics, triage and decision aids; Treatments for point of injury and austere environments; or Battlefield readiness. Proposals require preliminary data and must represent a mature research effort with a minimum biomedical Technology Readiness Level (TRL) of 4 or Knowledge Readiness Level (KRL) of 4. Independent investigators at all career levels are eligible, but an individual may be the Principal Investigator (PI) on only one application. The award may be structured as a base award with a maximum of $1.45M over 2 years, or as a base award plus a 1-year optional research phase, with a total cost cap of $2.45M over 3 years. A small-scale pilot clinical trial is only permissible during the optional phase. Funding is administered by the Defense Health Agency (DHA) as a grant or cooperative agreement.

Overall Technical Areas

Translational Trauma ResearchBattlefield Medical DiagnosticsClinical Decision Support ToolsProlonged Casualty CarePreclinical Animal ModelingPilot Clinical Trial DesignBiomedical Device DevelopmentTherapeutic Product DevelopmentStatistical Modeling & Data AnalysisFDA Regulatory StrategyAustere Environment MedicineMedical Knowledge Product DevelopmentGood Manufacturing Practices (GMP)Human Subjects Clinical Research

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:
  • Battlefield diagnostics, triage and decision aid tools: Solutions to enhance identification and management of trauma in point of injury, austere resuscitative and surgical care, prolonged casualty care and en route care environments
  • Advancement of clinical decision support tools and other automated technologies may support continued Force readiness and availability in combat environments and assist Warfighters in providing additional life-saving care where clinical capabilities are limited or non-existent.
  • The program seeks to develop innovative high-impact solutions to increase medical readiness; triage, diagnose and treat life-threatening injuries...
Specific Technical Skills:
Medical DiagnosticsTrauma TriageClinical Decision SupportPoint-of-Injury TechnologyAustere Environment MedicineProlonged Casualty CareEn Route CareAutomated TechnologiesTrauma ManagementSensor Development
Potential PIs for this Area:
NameScoreOrganization
Example Priorities:
  • Treatments: Solutions to enhance delivery of care in point of injury, austere resuscitative and surgical care, prolonged casualty care and en route care environments
  • accelerate the movement of promising ideas and/or technologies in trauma care into solutions to maximize casualty survivability, improve patient care closer to the point of injury and/or trauma care guidelines.
  • it is essential to bring effective and efficient life-saving capabilities closer to the point of injury and sustain prolonged care (greater than 72 hours) where necessary.
  • Mass casualty events that overwhelm immediately available medical capabilities... present a significant obstacle to providing damage control interventions closer to the point of need.
Specific Technical Skills:
Translational ResearchTrauma CareAustere Surgical CareResuscitative MedicinePoint-of-Injury TreatmentProlonged Field CarePreclinical Animal ModelsPilot Clinical TrialsDamage Control InterventionsMedical Product Development
Potential PIs for this Area:
NameScoreOrganization
Example Priorities:
  • Battlefield readiness: Solutions to address readiness with a focus on prehospital and operational environments
  • innovations developed by CRRP-supported research may be applied proactively to enhance medical readiness ahead of deployment, in operational settings at the point of injury, during periods of prolonged care, or during transport/en route between roles of care.
  • Innovations in technology and knowledge are critical to ensure front line provider skills sustainment to support rapid response in future operations.
  • The CRRP vision is to increase survivability and readiness of the Warfighter.
Specific Technical Skills:
Medical ReadinessPrehospital CareOperational MedicineProvider Skills SustainmentMilitary HealthKnowledge Product DevelopmentForce Health ProtectionCombat Casualty CareHuman PerformanceClinical Guideline Implementation
Potential PIs for this Area:
NameScoreOrganization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

NameScoreOrganization
Zixi Hu0.75CSA | AMCR | Mathematics · Statistical Modeling & Data Analysis
Zachary Jones0.73BSA | Biological Systems & Engineering | Process Engr & Analytics · Battlefield Medical Diagnostics
Harry Caufield0.72BSA | Env. Genomics & Sys. Biology | BioSystems Data Science · Medical Knowledge Product Development
Gerard Marriott0.72BSA | Molecular Biophysics & Integrated Bioimaging | Cellular & Tissue Image · Biomedical Device Development
Yi-Chuan Lu0.71EESA | CESD | Earth System Sciences · Austere Environment Medicine
Jian-Hua Mao0.71BSA | Biological Systems & Engineering | Department of BioEngineering and BioMedical Sciences · Preclinical Animal Modeling
Amy Kronenberg0.71BSA | Biological Systems & Engineering | Biodesign Dept · Human Subjects Clinical Research
Reginald Lee0.71PSA | Engineering | Mechanical Engineering · Translational Trauma Research
Jamie Inman0.71BSA | Biological Systems & Engineering | Department of BioEngineering and BioMedical Sciences · Prolonged Casualty Care
Seth Carbon0.71BSA | Env. Genomics & Sys. Biology | BioSystems Data Science · Good Manufacturing Practices (GMP)

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.